Drug profile · INN
methoxy polyethylene glycol-epoetin beta
MIRCERA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
methoxy polyethylene glycol-epoetin beta (MIRCERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN methoxy polyethylene glycol-epoetin beta
Brand MIRCERA
Route INJECTION
Formulation SOLUTION
ATC code B03XA03
Frequently asked questions
What is methoxy polyethylene glycol-epoetin beta?
methoxy polyethylene glycol-epoetin beta (MIRCERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for methoxy polyethylene glycol-epoetin beta?
MIRCERA is a marketed brand name for methoxy polyethylene glycol-epoetin beta. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methoxy polyethylene glycol-epoetin beta?
methoxy polyethylene glycol-epoetin beta has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.